Colon cancer is one of the most common cancers in the Western world, affecting more than 6% of the population during their lifetime. Colon cancer is more common in men, and about 90% of cancer cases occur after the age of 50. Several genetic variations are associated with the risk of developing the disease, and as part of this genetic test, an analysis of 17 genetic polymorphisms is performed (CASC8 rs6983267; CASC8 rs10505477; CASC8 rs10808555; CASC8 rs7837328; CASC8 rs7014346; CCND1 rs9344; CDH1 rs16260; COLCA1/COLCA2 rs3802842; CYP1A1 rs1048943; DNMT3B rs1569686; GREM1 rs10318; IL8/CXCL8 rs4073; IL10 rs1800872; MTHFR rs1801133; MTRR rs1801394; SMAD7 rs12953717; TGFB1 rs1800469) that provide information on the risk of disease development. Also, as part of the test, the patient receives information on preventive measures, and through the analysis of 9 genes, information is available on 32 drugs through their effect, speed of decomposition, and the necessary dose necessary to control the disease.
303.00€